Lets talk about Chronic Weight Management Since 2017 researchers have been actively discovering its benefits for chronic weight management
By the end, you will never second-guess the color of your tirzepatide again
Liraglutide, semaglutide and dulaglutide have demonstrated cardiovascular benefits, and Wegovy recently added to this evidence base: in the SELECT trial, patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a placebo
Its a very challenging disease, Marti Boss, first author of a new study published in The Journal of Nuclear Medicine , said in a statement
Im not worried, Im terrified, says 71-year-old Ann Rezarch, who takes compounded tirzepatide for lipedema and says she cannot afford the name-brand meds